Influence of analgesic active 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one on the antioxidant status, glucose utilization and lipid accumulation in some in vitro and ex vivo assays

References

• Abou-Seif MA, Youssef AA. (2004). Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta 346:161–70
   PubMed Web of Science ®Google Scholar
• Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L. (2008). Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol 8:33
   PubMed Web of Science ®Google Scholar
• Beutler E, Duron O, Kelly BM. (1963). Improvement method for the determination of blood glutathione. J Lab Clin Med 61:882–8
   PubMed Web of Science ®Google Scholar
• Bai H, Liu R, Chen HL, et al. (2013). Enhanced antioxidant effect of caffeic acid phenethyl ester and Trolox in combination against radiation induced-oxidative stress. Chem Biol Interact 6:7–15
   Google Scholar
• Bril V. (2012). Treatments for diabetic neuropathy. J Peripher Nerv Syst 17:22–7
   PubMed Web of Science ®Google Scholar
• Chong MS, Hester J. (2007). Diabetic painful neuropathy: current and future treatment options. Drugs 67:569–85
   PubMed Web of Science ®Google Scholar
• Derlacz RA, Hyc K, Usarek M, et al. (2008). PPAR-gamma-independent inhibitory effect of rosiglitazone on glucose synthesis in primary cultured rabbit kidney-cortex tubules. Biochem Cell Biol 86:396–404
   PubMed Web of Science ®Google Scholar
• Goldberg DM, Spooner RJ. (1983). Assay of glutathione reductase. In: Bergmeyen HV, ed. Methods of enzymatic analysis. Deerfield Beach (FL): Verlag Chemie, 258–65
   Google Scholar
• Hamid R, Rotshteyn Y, Rabadi L, et al. (2004). Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 18:703–10
   PubMed Web of Science ®Google Scholar
• Kumawat M, Sharma TK, Singh I, et al. (2013). Antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus patients with and without nephropathy. N Am J Med Sci 5:213–19
   PubMedGoogle Scholar
• Kuritzky L. (2010). Managing diabetic peripheral neuropathic pain in primary care. J Fam Pract 59:S15–22
   PubMed Web of Science ®Google Scholar
• Li YY, Wu HS, Tang L, et al. (2007). The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. Pharmacol Res 56:335–43
   PubMed Web of Science ®Google Scholar
• Maritim AC, Sanders RA, Watkins 3rd JB. (2003). Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24–38
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Hoener PA, Jow L, et al. (2000). A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 14:1425–33
   PubMed Web of Science ®Google Scholar
• Paglia D, Valentine W. (1967). Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–65
   PubMed Web of Science ®Google Scholar
• Pal P, Kanaujiya JK, Lochab S, et al. (2013). Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes. Mol Cell Biochem 376:81–93
   PubMed Web of Science ®Google Scholar
• Pluijms W, Huygen F, Cheng J, et al. (2011). Evidence-based interventional pain medicine according to clinical diagnoses. 18. Painful diabetic polyneuropathy. Pain Pract 11:191–8
   PubMed Web of Science ®Google Scholar
• Poitout V, Robertson RP. (2008). Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 29:351–66
   PubMed Web of Science ®Google Scholar
• Salat K, Filipek B, Wieckowski K, Malawska B. (2009). Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain. Pharmacol Rep 61:807–18
   PubMed Web of Science ®Google Scholar
• Salat K, Gawlik K, Witalis J, et al. (2013a). Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice. Naunyn Schmiedebergs Arch Pharmacol 386:493–505
   PubMed Web of Science ®Google Scholar
• Salat K, Librowski T, Nawiesniak B, Gluch-Lutwin M. (2013b). Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain. Neurol Res. 35:948–58
   Google Scholar
• Salat K, Moniczewski A, Salat R, et al. (2012). Analgesic, anticonvulsant and antioxidant activities of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one dihydrochloride in mice. Pharmacol Biochem Behav 101:138–47
   PubMed Web of Science ®Google Scholar
• Salat R, Salat K. (2013). The application of support vector regression for prediction of the antiallodynic effect of drug combinations in the mouse model of streptozocin-induced diabetic neuropathy. Comput Methods Programs Biomed 111:330–7
   PubMed Web of Science ®Google Scholar
• Satoh J, Yagihashi S, Baba M, et al. (2011). Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabet Med 28:109–16
   PubMed Web of Science ®Google Scholar
• Sharma S, Kulkarni SK, Agrewala JN, Chopra K. (2006). Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 536:256–61
   PubMed Web of Science ®Google Scholar
• Takazawa T, Yamauchi T, Tsuchida A, et al. (2009). Peroxisome proliferator-activated receptor gamma agonist rosiglitazone increases expression of very low density lipoprotein receptor gene in adipocytes. J Biol Chem 284:30049–57
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Selvarajah D. (2012). Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. Diabetes Metab Res Rev 28:8–14
   PubMed Web of Science ®Google Scholar
• Várkonyi T, Kempler P. (2008). Diabetic neuropathy: new strategies for treatment. Diabetes Obes Metab 10:99–108
   PubMed Web of Science ®Google Scholar
• Vinik A. (2005). Clinical review: use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab 90:4936–45
   PubMed Web of Science ®Google Scholar
• Zhang M, Swarts SG, Yin L, et al. (2011). Antioxidant properties of quercetin. Adv Exp Med Biol 701:283–9
   PubMed Web of Science ®Google Scholar
• Ziegler D. (2008). Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab Res Rev 24:S52–7
   Google Scholar
• Zilliox L, Russell JW. (2011). Treatment of diabetic sensory polyneuropathy. Curr Treat Options Neurol 13:143–59
   PubMed Web of Science ®Google Scholar